Reclassifying insulins

Michael D. Feher*, Clifford J. Bailey

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Insulins have hitherto been distinguished as clear (short-acting) and cloudy (long-acting). However the introduction of glargine, which is clear long-acting insulin, has prompted the need for reclassification. In view of the increasing emphasis on intensive insulin therapy using basal-regimens, a new, simple, pragmatic classification is suggested in which insulin are categorised according to the timing and purpose of administration: basal (maintenance), bolus (meal) and biphasic (mixed).

Original languageEnglish
Pages (from-to)39-42
Number of pages4
JournalBritish Journal of Diabetes and Vascular Disease
Issue number1
Publication statusPublished - 1 Jan 2004


  • Basal insulins
  • Biphasic insulins
  • Bolus insulins
  • Insulin


Dive into the research topics of 'Reclassifying insulins'. Together they form a unique fingerprint.

Cite this